Delayed cerebral ischemia is a leading complication in the severe form of stroke known as subarachnoid hemorrhage and can result in long-term neurological damage, disability, or death.

An international discovery collaboration is harnessing AI-powered drug discovery to develop a first-in-class therapy to prevent delayed cerebral ischemia in patients with subarachnoid hemorrhage. The ...

Findings from three patients in a gene therapy clinical trial showed that gene therapy treatment significantly improved blood ...

Dr. Gérald Kierzek, emergency physician, reveals the hidden nighttime signs and what they could mean for your health.

Recent study investigates the pathophysiology of hypoxic-ischemic encephalopathy (HIE) in patients following cardiac arrest ...

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children's Research Hospital.

The pig’s heart was graying rapidly, so McCully decided to try it. He loaded a syringe with the extracted mitochondria and ...

The outcome and infarction size after focal cerebral ischemia is determined in part by delayed neuronal cell death in the borderzone of ischemia.

University of Utah researchers believe inflammation starts a months-long process that increases risk of aneurysm rupture.

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Many people with sickle cell disease experience increased brain ischemia, where oxygen is not delivered properly to brain tissues, potentially leading to strokes. A part of the risk for these events ...